Artificial Intelligence Opportunities are Sky Rocketing as Global AI In Healthcare Market is Projected to Reach $504 Billion by 2032
XORTX Announces Pricing of US$1.1 Million Registered Direct Offering
Rocket Doctor Expands U.S. Coverage, Becoming In-Network with Two Leading National Insurers With More Than 6.5 Million Additional Members Across California and New York State
BriaCell Adds Key Clinical Sites in Phase 3 Metastatic Breast Cancer Study
BriaCell Announces Collaboration with MSK Accelerator to Advance Bria-OTS+(TM) for Breast Cancer
Cardiol Therapeutics Completes US$11.4 Million Financing and Extends Cash Runway into Q3 2027
TempraMed Announces Private Placement of up to C$2.5 Million
Satellos Announces First Adult Patient Dosed in LT-001, an Open-Label, Long-Term Follow-Up Study of SAT-3247 in Duchenne Muscular Dystrophy
Pangenomic expands Nara.Care with DNA program launch
Nxera's Partner Cancer Research UK Presents Data from Successfully Completed Phase 1 Clinical Trial of Cancer Immunotherapy Drug HTL0039732 at ESMO
BioNxt Launches 15-day Sublingual Cladribine Dosing Optimization Study in Preparation for Human Bioequivalence Study
PanGenomic Health Expands NaraCare.AI Platform with Launch of DNA Testing Program
BIOVAXYS ANNOUNCES CONVERSION OF DEBENTURES AND GRANT OF STOCK OPTIONS
Quantum Biopharma warrants issued to funds expire
Briacell presents phase 3 biomarker data at ESMO 2025